Claudia Iavarone

*Email*	[email protected]
*Telephone*	0294375016
*Location*	Building 1 Floor 1st Via Adamello 16, Milano

Member of

Transfer Office (IEO-TT) - Senior Specialist

I graduated in Medical Biotechnology at Università degli Studi di Napoli "Federico II" in Naples and I hold a PhD degree in Molecular Medicine from SEMM - European School of Molecular Medicine in Milan. I have 10 years experience in biomedical research, in particular in preclinical translation research in breast and ovarian cancer. From 2014 to 2018 I worked as Postdoctoral Fellow in the research group of Joan’s Brugge at Harvard Medical School in Boston (USA). I am co-author in several peer-reviewed scientific publications. I have competencies in general principles of clinical research, business administration and marketing &business development.

Most Relevant Publications

Lomoriello IS, Giangreco G, Iavarone C, Tordonato C, Caldieri G, Serio G, Confalonieri S, Freddi S, Bianchi F, Pirroni S, Bertalot G, Viale G, Disalvatore D, Tosoni D, Malabarba MG, Disanza A, Scita G, Pece S, Pilcher BK, Vecchi M, Sigismund S, Di Fiore PP

A Self-Sustaining Endocytic-Based Loop Promotes Breast Cancer Plasticity Leading to Aggressiveness and Pro-Metastatic Behavior.

Nat Commun, 2020
Claudia Iavarone, Ioannis K Zervantonakis, Laura M Selfors, Sangeetha Palakurthi, Joyce F Liu, Ronny Drapkin, Ursula A Matulonis, Dorothy Hallberg, Victor E Velculescu, Joel D Leverson, Deepak Sampath, Gordon B Mills, Joan S Brugge

Combined MEK and BCL-2/XL Inhibition Is Effective in High-Grade Serous Ovarian Cancer Patient-Derived Xenograft Models and BIM Levels Are Predictive of Responsiveness

Mol Cancer Ther, 2019
Ioannis K Zervantonakis, Claudia Iavarone, Hsing-Yu Chen, Laura M Selfors, Sangeetha Palakurthi, Joyce F Liu, Ronny Drapkin, Ursula Matulonis, Joel D Leverson, Deepak Sampath, Gordon B Mills, Joan S Brugge

Systems analysis of apoptotic priming in ovarian cancer identifies vulnerabilities and predictors of drug response

Nat Commun, 2017
Marcin P Iwanicki, Hsing-Yu Chen, Claudia Iavarone, Ioannis K Zervantonakis, Taru Muranen, Marián Novak, Tan A Ince, Ronny Drapkin, Joan S Brugge

Mutant p53 regulates ovarian cancer transformed phenotypes through autocrine matrix deposition

JCI Insight, 2016

Claudia Iavarone

Claudia Iavarone

Most Relevant Publications

A Self-Sustaining Endocytic-Based Loop Promotes Breast Cancer Plasticity Leading to Aggressiveness and Pro-Metastatic Behavior.

Combined MEK and BCL-2/XL Inhibition Is Effective in High-Grade Serous Ovarian Cancer Patient-Derived Xenograft Models and BIM Levels Are Predictive of Responsiveness

Systems analysis of apoptotic priming in ovarian cancer identifies vulnerabilities and predictors of drug response

Mutant p53 regulates ovarian cancer transformed phenotypes through autocrine matrix deposition